Lowering the Prophylactic Platelet Transfusion Threshold: a Prospective Analysis

References

• Hersh E M, Bodey G P, Nies B A, Freireich E J. Causes of death in acute leukemia. JAMA 1965; 193: 99–103
   PubMed Web of Science ®Google Scholar
• Han T, Stutzman L, Cohen E, Kim U. Effect of platelet transfusion on hemorrhage in patients with acute leukemia. An autopsy study. Cancer 1966; 19: 1937–1942
   PubMed Web of Science ®Google Scholar
• Hamajima N, Sasaki R, Aoki K, Shibata A. A notable change in mortality of aplastic anemia observed during the 1970s in Japan. Blood 1988; 72: 995–999
   PubMed Web of Science ®Google Scholar
• Baer M R, Bloomfield C D. Controversies in transfusion medicine. Prophylactic platelet transfusion therapy: pro. Transfusion 1992; 32: 377–380
   PubMed Web of Science ®Google Scholar
• Armitage J O. Bone marrow transplantation. N Engl J Med 1994; 330: 827–838
   PubMed Web of Science ®Google Scholar
• McCullough J, Steeper T A, Connelly D P, Jackson B, Huntington S, Scott E P. Platelet utilization in a university hospital. JAMA 1988; 259: 2414–2418
   PubMed Web of Science ®Google Scholar
• Pisciotto P T, Benson K, Hume H, Glassman A B, Oberman H, Popovsky M, Hines D, Anderson K. Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients. Transfusion 1995; 35: 498–502
   PubMed Web of Science ®Google Scholar
• Beutler E. Platelet transfusions: the 20,000/μl trigger. Blood 1993; 81: 1411–1413
   PubMed Web of Science ®Google Scholar
• Patten E. Controversies in transfusion medicine. Prophylactic platelet transfusion revisited after 25 years: con. Transfusion 1992; 32: 381–385
   PubMed Web of Science ®Google Scholar
• NIH Consensus Development Conference on Platelet Transfusion Therapy. Platelet transfusion therapy. JAMA 1987; 257: 1777–1780
   PubMed Web of Science ®Google Scholar
• Morrow J F, Braine H G, Kickler T S, Ness P M, Dick J D, Fuller A K. Septic reactions to platelet transfusions. A persistent problem. JAMA 1991; 266: 555–558
   PubMed Web of Science ®Google Scholar
• Yomtovian R, Lazarus H M, Goodnough L T, Hirschler N V, Morrissey A M, Jacobs M R. A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets. Transfusion 1993; 33: 902–909
   PubMed Web of Science ®Google Scholar
• Hett S J, Lilleyman J S. Platelet transfusion requirements of children with newly diagnosed lymphoblastic leukaemia. Acta Haemat 1979; 62: 86–89
   PubMed Web of Science ®Google Scholar
• Murphy S, Litwin S, Herring L M, Koch P, Remischovsky J, Donaldson M H, Evans A E, Gardner F H. Indications for platelet transfusion in children with acute leukemia. Am J Hematol 1982; 12: 347–356
   PubMed Web of Science ®Google Scholar
• Aderka D, Praff G, Santo M, Weinberger A, Pinkhas J. Bleeding due to thrombocytopenia in acute leukemias and reevaluation of the prophylactic platelet transfusion policy. Am J Med Sci 1986; 291: 147–151
   PubMed Web of Science ®Google Scholar
• Slichter S J. Platelet transfusion therapy. Hematol Oncol Clin N Am 1990; 4: 291–311
   PubMed Web of Science ®Google Scholar
• Gmür J, Burger J, Schanz U, Fehr J, Schaffner A. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukemia. Lancet 1991; 338: 1223–1226
   PubMed Web of Science ®Google Scholar
• Kelsey H C. An audit of the use of platelet concentrates in the prophylaxis of thrombocytopenic haemorrhage in a large haematology unit. Blood Coag Fibrinolysis 1992; 3: 647–649
   PubMed Web of Science ®Google Scholar
• Rintels P B, Kenney R M, Crowley J P. Therapeutic support of the patient with thrombocytopenia. Hematol Oncol Clin N Am 1994; 8: 1131–1157
   PubMed Web of Science ®Google Scholar
• Machin S J, Kelsey H, Seghatchian M J, Warwick R, Mackie U. Platelet transfusion. Thromb Haemostas 1995; 74: 246–252
   PubMed Web of Science ®Google Scholar
• Heckman K D, Weiner G J, Davis C S, Strauss R G, Jones M P, Burns C P. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/μL versus 20,000/μL. J Clin Oncol 1997; 15: 1143–1149
   PubMed Web of Science ®Google Scholar
• Rebulla P, Finazzi G, Marangoni F, Avvisati G, Gugliotta L, Tognoni G, Barbui T, Mandelli F, Sirchia G. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. New Engl J Med 1997; 337: 1870–1875
   PubMed Web of Science ®Google Scholar
• Sagmeister M, Oec L, Gmür J. A restrictive platelet transfusion policy allowing long-term support of outpatients with severe aplastic anemia. Blood 1999; 93: 3124–3126
   PubMed Web of Science ®Google Scholar
• Rinder H M, Arbini A A, Snyder E L. Optimal dosing and triggers for prophylactic use of platelet transfusions. Curr Opin Hematol 1999; 6: 437–441
   PubMedGoogle Scholar
• Ancliff P J, Machin S J. Trigger factors for prophylactic platelet transfusion. Blood Rev 1998; 12: 234–238
   PubMed Web of Science ®Google Scholar
• Navarro J T, Hernandez J A, Ribera J M, Sancho J M, Oriol A, Pujol M, Milla F, Feliu E. Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/μL versus 20,000/μL. Haematologica 1998; 83: 998–1000
   PubMed Web of Science ®Google Scholar
• Solomon J, Bofenkamp T, Fahey J L, Chillar R K, Beutler E. Platelet prophylaxis in acute non-lymphoblastic leukaemia. Lancet 1978; 1: 267
   PubMed Web of Science ®Google Scholar
• Higby D J, Cohen E, Holland J F, Sinks L. The prophylactic treatment of thrombocytopenic leukemic patients with platelets: a double blind study. Transfusion 1974; 14: 440–446
   PubMed Web of Science ®Google Scholar
• Wandt H, Frank M, Ehninger G, Schneider C, Brack N, Daoud A, Fackler-Schwalbe I, Fischer J, Gackle R, Geer T, Harms P, Loffler B, Ohl S, Otremba B, Raab M, Schonrock-Nabulsi P, Strobel G, Winter R, Link H. Safety and cost effectiveness of a 10 ± 109/L trigger for prophylactic platelet transfusions compared with the traditional 20 ± 109/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood 1998; 91: 3101–3106
   Google Scholar
• Lawrence J B, Yomtovian R A, Dillman C, Masarik S R, Chongkolwatana V, Creger R J, Manka A, Mammons T, Lazarus H M. Reliability of automated platelet counts: Comparison with manual method and utility for prediction of clinical bleeding. Am J Hematol 1995; 48: 244–250
   PubMed Web of Science ®Google Scholar
• Gaydos L A, Freireich E J, Mantel N. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. New Engl J Med 1962; 266: 905–909
   PubMed Web of Science ®Google Scholar
• Freireich E J. Effectiveness of platelet transfusion in leukemia and aplastic anemia. Transfusion 1966; 6: 50–54
   Web of Science ®Google Scholar
• Gil-Fernandez J J, Alegre A, Fernandez-Villalta M J, Pinilla I, Gomez Garcia V, Martinez C, Tomas J F, Arranz R, Figuera A, Camara R, Fernandez-Ranada J M. Clinical results of a stringent policy on prophylactic platelet transfusion: non-randomized comparative analysis in 190 bone marrow transplant patients from a single institution. Bone Marrow Transplant 1996; 18: 931–935
   PubMed Web of Science ®Google Scholar
• van Eys J, Thomas D, Olivos B. Platelet use in pediatric oncology: A review of 393 transfusions. Transfusion 1978; 18: 169–173
   PubMed Web of Science ®Google Scholar
• Nielsen H J, Werther K, Mynster T, Brunner N. Soluble vascular endothelial growth factor in various blood transfusion components. Transfusion 1999; 39: 1078–1083
   PubMed Web of Science ®Google Scholar
• Heyman M R, Schiffer C A. Platelet transfusion for the cancer patient. Semin Oncol 1990; 17: 198–209
   PubMed Web of Science ®Google Scholar
• Freeman G, Buckley E SB, Jr. Serum polysaccharide and fever in thrombocytopenic bleeding of leukemia. Blood 1954; 9: 586–594
   PubMed Web of Science ®Google Scholar
• Brown C H, III, Natelson E A, Bradshaw M W, Williams T W, Jr, Alfrey C P, Jr. The hemostatic defect produced by carbenicillin. New Engl J Med 1974; 291: 265–270
   PubMed Web of Science ®Google Scholar
• Brown C H, III, Bradshaw M W, Natelson E A, Alfrey C P, Jr, Williams T W, Jr. Defective platelet function following the administration of penicillin compounds. Blood 1976; 47: 949–956
   PubMed Web of Science ®Google Scholar
• Burroughs S F, Johnson G J. Beta-lactam antibiotics inhibit agonist-stimulated platelet calcium influx. Thromb Haemostas 1993; 69: 503–508
   PubMed Web of Science ®Google Scholar
• Kulpa J, Zaroulis C G, Good R A, Kutti J. Altered platelet function and circulation induced by amphotericin B in leukemic patients after platelet transfusion. Transfusion 1981; 21: 74–76
   PubMed Web of Science ®Google Scholar
• McGrath K, Bertram J F, Houghton S, Boothman J, Manderson J A, Minchinton R. Amphotericin B-induced injury in stored human platelets. Transfusion 1992; 32: 46–50
   PubMed Web of Science ®Google Scholar
• Murphy S, Amphotericin B. Platelet transfusion. Transfusion 1992; 32: 7–8
   PubMed Web of Science ®Google Scholar
• Bishop J F, McGrath K, Wolf M M, Matthews J P, De Luise T, Holdsworth R, Yuen K, Veale M, Whiteside M G, Cooper I A, Szer J. Clinical factors influencing the efficacy of pooled platelet transfusions. Blood 1988; 71: 383–387
   PubMed Web of Science ®Google Scholar
• McFarland J G, Anderson A J, Slichter S J. Factors influencing the transfusion response to HLA-selected apheresis donor platelets in patients refractory to random platelet concentrates. Br J Haematol 1989; 73: 380–386
   PubMed Web of Science ®Google Scholar
• Bishop J F, Matthews J P, McGrath K, Yuen K, Wolf W W, Szer J. Factors influencing 20-hour increments after platelet transfusion. Transfusion 1991; 31: 392–396
   PubMed Web of Science ®Google Scholar
• Friedberg R C, Donnelly S F, Boyd J C, Gray L S, Mintz P D. Clinical and blood bank factors in the management of platelet refractoriness and alloimmunization. Blood 1993; 81: 3428–3434
   PubMed Web of Science ®Google Scholar
• Ishida A, Handa M, Wakui M, Okamoto S, Kamakura M, Ikeda Y. Clinical factors influencing post-transfusion platelet increment in patients undergoing hematopoietic progenitor cell transplantation-a prospective analysis. Transfusion 1998; 38: 839–847
   PubMed Web of Science ®Google Scholar